Mirabegron 50 MG [Myrbetriq]

DRUG2 trials

Sponsors

University Hospitals Cleveland Medical Center, Walter Reed National Military Medical Center

Conditions

Overactive BladderOveractive Bladder Syndrome

Phase 4

Vaginal Estradiol vs Oral Beta-3 Agonist for Overactive Bladder Syndrome

RecruitingNCT05221021

Walter Reed National Military Medical CenterOveractive Bladder Syndrome

Start: 2022-10-01End: 2027-01-30Target: 152Updated: 2024-08-19

Unknown Phase

Comparison of Electroacupuncture to Mirabegron for Treatment of Overactive Bladder

WithdrawnNCT03087578

University Hospitals Cleveland Medical CenterOveractive Bladder

Start: 2017-07-01End: 2018-09-30Updated: 2022-05-06